![Raafat E. F. Fahim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raafat E. F. Fahim
Direttore/Membro del Consiglio presso BIOTA HOLDINGS LTD.
Profilo
Raafat E.
F.
Fahim is currently the Non-Executive Chairman at VM Farms, Inc. and a Non-Executive Director at Biota Holdings Pty Ltd.
He previously served as President, CEO, CFO & Director at Nabi Biopharmaceuticals from 2003 to 2012, President & Chief Operating Officer at Aptose Biosciences, Inc. from 2001 to 2002, and VP-Development, Quality & Industrial Operations at Sanofi Pasteur, Inc. from 1987 to 2001.
He also served as a Non-Executive Director at Aviragen Therapeutics, Inc. from 2012 to 2013.
Fahim holds a doctorate degree from the University of Toronto.
Posizioni attive di Raafat E. F. Fahim
Società | Posizione | Inizio |
---|---|---|
BIOTA HOLDINGS LTD. | Direttore/Membro del Consiglio | 01/01/2008 |
VM Farms, Inc.
![]() VM Farms, Inc. Data Processing ServicesTechnology Services VM Farms, Inc. provides internet services. It specializes in cloud provider, application deployment, application scaling, application management, operations-as-a-service, devops, system administration, hosting and system security. The company was founded by Hany Fahim and is headquartered in Toronto, Canada. | Presidente | - |
Precedenti posizioni note di Raafat E. F. Fahim
Società | Posizione | Fine |
---|---|---|
Aviragen Therapeutics, Inc.
![]() Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Direttore/Membro del Consiglio | 30/04/2013 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Presidente | 12/11/2012 |
APTOSE BIOSCIENCES INC. | Presidente | 01/01/2002 |
Sanofi Pasteur, Inc.
![]() Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Corporate Officer/Principal | 01/01/2001 |
Formazione di Raafat E. F. Fahim
University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
APTOSE BIOSCIENCES INC. | Health Technology |
Aziende private | 5 |
---|---|
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
Sanofi Pasteur, Inc.
![]() Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Biota Holdings Pty Ltd.
![]() Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Biota Holdings Pty Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia. | Health Technology |
Aviragen Therapeutics, Inc.
![]() Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
VM Farms, Inc.
![]() VM Farms, Inc. Data Processing ServicesTechnology Services VM Farms, Inc. provides internet services. It specializes in cloud provider, application deployment, application scaling, application management, operations-as-a-service, devops, system administration, hosting and system security. The company was founded by Hany Fahim and is headquartered in Toronto, Canada. | Technology Services |
- Borsa valori
- Insiders
- Raafat E. F. Fahim